HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome.

Abstract
A 6-year-old female diagnosed with idiopathic opsoclonus-myoclonus syndrome at 22 months of age who failed to respond to treatment with adrenocorticotropic hormone (ACTH), IV gammaglobulin (IVIG), and azathioprine is presented. Because of marked and progressive deterioration in motor function and speech, this patient received a course of plasmapheresis with concomitant steroids and azathioprine. Within 1 week, marked improvements in motor function were noted. Eighteen months later, the patient ambulates, walks without support, and attends a regular school in the appropriate grade level.
AuthorsV W Yiu, T Kovithavongs, L F McGonigle, P Ferreira
JournalPediatric neurology (Pediatr Neurol) Vol. 24 Issue 1 Pg. 72-4 (Jan 2001) ISSN: 0887-8994 [Print] United States
PMID11182286 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Azathioprine
  • Prednisone
Topics
  • Azathioprine (administration & dosage)
  • Child
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Humans
  • Neurologic Examination (drug effects)
  • Paraneoplastic Syndromes, Nervous System (diagnosis, therapy)
  • Plasmapheresis
  • Prednisone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: